Off the Shelf: Paratek & Project BioShield
Update: 2025-01-10
Description
This week Dr. Evan Loh, Paratek CEO, returns to Off the
Shelf to share the latest in the biopharmaceutical company’s partnership with
the Biomedical Advanced Research and Development Authority’s (BARDA’s)
Project BioShield.
Paratek’s antibiotic, NUZYRA (omadacycline) has been
designated “an essential” medicine by the FDA, and Loh provides an update
on the progress made in onshoring of manufacturing of NUZYRA, from the
production of API through finished drug product for both IV and oral
formulations.
Loh shares the journey to domestic manufacturing, highlighting the critical role Paratek’s public-private partnership with BARDA played in developing manufacturing capability.
Antimicrobial resistance (AMR) along with biological threat actors are continuing and growing threat and Loh discusses the current environment and the key policy considerations in
combatting these and other healthcare threats.
Finally, Loh talks about the potential that the results from the successful development of treatments through public-partnerships have the potential to be leveraged to support/protect
the warfighter.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
Shelf to share the latest in the biopharmaceutical company’s partnership with
the Biomedical Advanced Research and Development Authority’s (BARDA’s)
Project BioShield.
Paratek’s antibiotic, NUZYRA (omadacycline) has been
designated “an essential” medicine by the FDA, and Loh provides an update
on the progress made in onshoring of manufacturing of NUZYRA, from the
production of API through finished drug product for both IV and oral
formulations.
Loh shares the journey to domestic manufacturing, highlighting the critical role Paratek’s public-private partnership with BARDA played in developing manufacturing capability.
Antimicrobial resistance (AMR) along with biological threat actors are continuing and growing threat and Loh discusses the current environment and the key policy considerations in
combatting these and other healthcare threats.
Finally, Loh talks about the potential that the results from the successful development of treatments through public-partnerships have the potential to be leveraged to support/protect
the warfighter.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
Episode:
Podcast: https://federalnewsnetwork.com/shows/off-the-shelf-podcast/
Comments
Top Podcasts
The Best New Comedy Podcast Right Now – June 2024The Best News Podcast Right Now – June 2024The Best New Business Podcast Right Now – June 2024The Best New Sports Podcast Right Now – June 2024The Best New True Crime Podcast Right Now – June 2024The Best New Joe Rogan Experience Podcast Right Now – June 20The Best New Dan Bongino Show Podcast Right Now – June 20The Best New Mark Levin Podcast – June 2024
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
